Musa Karakükçü

2.2k total citations
102 papers, 770 citations indexed

About

Musa Karakükçü is a scholar working on Hematology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Musa Karakükçü has authored 102 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 19 papers in Molecular Biology and 18 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Musa Karakükçü's work include Immunodeficiency and Autoimmune Disorders (9 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Erythrocyte Function and Pathophysiology (7 papers). Musa Karakükçü is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (9 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Erythrocyte Function and Pathophysiology (7 papers). Musa Karakükçü collaborates with scholars based in Türkiye, United States and Germany. Musa Karakükçü's co-authors include Türkan Patıroğlu, Ekrem Ünal, Hakan Gümüş, Selim Kurtoğlu, Mehmet Akif Özdemir, Sefer Kumandaş, Alper Özcan, Hüseyin Per, Tamer Güneş and Esad Köklü and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Musa Karakükçü

91 papers receiving 735 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Musa Karakükçü Türkiye 13 190 147 137 114 104 102 770
İdil Yenicesu Türkiye 16 410 2.2× 71 0.5× 99 0.7× 160 1.4× 64 0.6× 70 837
Satya Prakash Yadav India 12 155 0.8× 101 0.7× 106 0.8× 65 0.6× 134 1.3× 98 627
Jörn‐Sven Kühl Germany 16 207 1.1× 101 0.7× 133 1.0× 54 0.5× 149 1.4× 43 905
Jill Adamski United States 17 200 1.1× 296 2.0× 50 0.4× 82 0.7× 71 0.7× 48 1.0k
Mikko Perkkiö Finland 20 230 1.2× 98 0.7× 233 1.7× 93 0.8× 193 1.9× 45 1.1k
Marianne Ifversen Denmark 16 348 1.8× 169 1.1× 163 1.2× 41 0.4× 62 0.6× 64 836
Iou‐Jih Hung Taiwan 19 448 2.4× 96 0.7× 287 2.1× 198 1.7× 80 0.8× 88 1.2k
Mehmet Sinan Dal Türkiye 12 129 0.7× 61 0.4× 43 0.3× 82 0.7× 44 0.4× 118 580
Francisco Barriga Chile 17 107 0.6× 146 1.0× 90 0.7× 207 1.8× 101 1.0× 56 1.4k
M. Contreras United Kingdom 21 552 2.9× 258 1.8× 112 0.8× 170 1.5× 173 1.7× 50 1.2k

Countries citing papers authored by Musa Karakükçü

Since Specialization
Citations

This map shows the geographic impact of Musa Karakükçü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Musa Karakükçü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Musa Karakükçü more than expected).

Fields of papers citing papers by Musa Karakükçü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Musa Karakükçü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Musa Karakükçü. The network helps show where Musa Karakükçü may publish in the future.

Co-authorship network of co-authors of Musa Karakükçü

This figure shows the co-authorship network connecting the top 25 collaborators of Musa Karakükçü. A scholar is included among the top collaborators of Musa Karakükçü based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Musa Karakükçü. Musa Karakükçü is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erbey, Fatih, Ebru Yılmaz, Musa Karakükçü, et al.. (2025). Successful Use of Haploidentical HSCT in a Child With Schimke Immuno‐Osseous Dysplasia Who Developed PTLD After Kidney Transplantation. Pediatric Transplantation. 29(8). e70234–e70234.
2.
Özcan, Alper, Ebru Yılmaz, Atıl Bişgin, et al.. (2025). Clinical and laboratory aspects of patients diagnosed with various inherited platelet disorders. Research and Practice in Thrombosis and Haemostasis. 9(4). 102873–102873.
3.
Özcan, Alper, Ebru Yılmaz, Musa Karakükçü, et al.. (2024). Alantolactone ameliorates graft versus host disease in mice. International Immunopharmacology. 128. 111560–111560. 4 indexed citations
4.
Huri̇, Meral, et al.. (2023). The Resilience Scale for Parents of Children with Cancer: Scale development and psychometric evaluation. Psycho-Oncology. 32(6). 951–960. 4 indexed citations
5.
Gökahmetoğlu, Selma, et al.. (2023). Determination of Genotypes in Cytomegalovirus (CMV) Strains Obtained from Pediatric and Adult Immunocompromised Patients. Journal of Basic and Clinical Health Sciences. 7(1). 270–276. 1 indexed citations
6.
Alp, Emine, Zeynep Burçin Gönen, Kürşat Gündoğan, et al.. (2022). The Effect of Mesenchymal Stromal Cells on the Mortality of Patients with Sepsis and Septic Shock: A Promising Therapy. Emergency Medicine International. 2022. 1–9. 18 indexed citations
7.
8.
Yılmaz, Ebru, Alper Özcan, Hüseyin Per, et al.. (2022). Intracranial hemorrhage in children with hemophilia. 1(3). 85–88.
9.
Köker, Mustafa Yavuz, Nazan Sarper, Canan Albayrak, et al.. (2021). New αIIbβ3 variants in 28 Turkish Glanzmann patients; structural hypothesis for complex activation by residues variations in I-EGF domains. Platelets. 33(4). 551–561. 3 indexed citations
10.
Canpolat, Mehmet, Hüseyin Per, Abdulhakim Çoşkun, et al.. (2021). Long-Term Follow-Up of Patients with a Diagnosis of Posterior Reversible Encephalopathy Syndrome. Turkish Archives of Pediatrics. 56(6). 569–575.
11.
Yılmaz, Ebru, et al.. (2021). Transplantation for ultra high-risk neuroblastoma patients: effect of tandem autologous stem cell transplantation. DergiPark (Istanbul University).
12.
Yılmaz, Ebru, et al.. (2021). Transplantation for ultra high-risk neuroblastoma patients: effect of tandem autologous stem cell transplantation. Journal of Health Sciences and Medicine. 4(6). 943–948.
13.
Özcan, Alper, et al.. (2020). Long-Term Patient-Customized Therapy for a Pathogenic EPO Mutation. Med. 2(1). 33–37.e1. 1 indexed citations
14.
15.
Gökahmetoğlu, Selma, et al.. (2020). İmmün Yetmezlikli Hastalardan Elde Edilen Sitomegalovirüs İzolatlarındaki Gansiklovir Direncinin Araştırılması. Mikrobiyoloji Bulteni. 54(4). 619–628. 2 indexed citations
16.
Ünal, Ekrem, Ebru Yılmaz, Alper Özcan, et al.. (2019). Twenty children with non-Wilms renal tumors from a reference center in Central Anatolia, Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES. 50(1). 18–24. 4 indexed citations
17.
Somekh, Ido, Yanshan Liu, Meino Rohlfs, et al.. (2018). Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma. Journal of Clinical Immunology. 38(6). 699–710. 37 indexed citations
18.
Patıroğlu, Türkan, Catherine B. Klein, Maximilian Witzel, et al.. (2016). CLINICAL FEATURES AND GENETIC ANALYSIS OF SIX PATIENTS WITH WISKOTT-ALDRICH SYNDROME REPORTING TWO NOVEL MUTATIONS: EXPERIENCE OF ERCIYES UNIVERSITY, KAYSERI, TURKEY.. PubMed. 27(1). 9–24. 5 indexed citations
19.
Patıroğlu, Türkan, Himmet Haluk Akar, Ekrem Ünal, et al.. (2015). Malignancies in Primary Immunodeficiencies: A Single Center Experience. Pediatric Allergy Immunology and Pulmonology. 28(1). 47–54. 6 indexed citations
20.
Patıroğlu, Türkan, Ekrem Ünal, Musa Karakükçü, et al.. (2012). Multiple Fungal Brain Abscesses in a Child with Acute Lymphoblastic Leukemia. Mycopathologia. 174(5-6). 505–509. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by İdil Yenicesu Breakdown of academic impact, for papers by Satya Prakash Yadav Breakdown of academic impact, for papers by Jörn‐Sven Kühl Breakdown of academic impact, for papers by Jill Adamski Breakdown of academic impact, for papers by Mikko Perkkiö Breakdown of academic impact, for papers by Marianne Ifversen Breakdown of academic impact, for papers by Iou‐Jih Hung Breakdown of academic impact, for papers by Mehmet Sinan Dal Breakdown of academic impact, for papers by Francisco Barriga Breakdown of academic impact, for papers by M. Contreras
Rankless by CCL
2026